UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012343 |
|---|---|
| Receipt number | R000014417 |
| Scientific Title | Phase II study of nab-paclitaxel for relapsed non-small cell lung cancer (NLCTG1302) |
| Date of disclosure of the study information | 2013/11/19 |
| Last modified on | 2019/08/06 08:10:25 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/11/19 13:35:37 | ||
| 2 | Update | 2014/05/21 10:56:57 | Name of person sending information Name of person sending information |
|
| 3 | Update | 2015/05/29 14:21:36 | Division name Division name |
|
| 4 | Update | 2016/05/12 10:11:05 | Name of person sending information Name of person sending information Division name Division name TEL Name of primary person or sponsor Organization |
|
| 5 | Update | 2018/06/14 10:49:33 | Name of person sending information Name of person sending information TEL |
|
| 6 | Update | 2019/08/04 10:26:17 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Organization Organization Address Address Tel |
|
| 7 | Update | 2019/08/06 08:08:58 | Date of IRB Last follow-up date |
|
| 8 | Update | 2019/08/06 08:09:20 | Recruitment status |
|
| 9 | Update | 2019/08/06 08:10:25 | Number of participants that the trial has enrolled |
